ChangF., SyrjanenS., TervahautaA.. Tumourigenesis associated with the p53 tumour suppressor gene.Br J Cancer.1993; 68: 653–661.
2.
EvansA.S., MuellerN.E.. Viruses and cancer: causal associations.Ann Epidemiol.1990; 1: 71–92.
3.
MaimanM.. HIV infection and cervical neoplasia.Resident Staff Physic.1996; 42: 34–45.
4.
EpsteinM.A.. Viral infections and cancer in the tropics.Trop Geogr Med.1988; 40: S52–60.
5.
GruberJ., ColeJSIII. Vaccines for human cancers of viral etiology.Ann N Y Acad Sci.1993; 690: 311–321.
6.
ParsonnetJ.. Bacterial infection as a cause of cancer.Environ Health Perspect.1995; 103(suppl 8): 263–268.
7.
KinoshitaT., IshiiK., TairaY.. Malignant lymphoma arising from chronic tuberculous empyema. A case report.Acta Radiol.1997; 38: 833–835.
8.
MolinieV., PouchotJ., NavratilE.. Primary Epstein-Barr virus related non-Hodgkin's lymphoma of the pleural cavity following long-standing tuberculous empyema.Arch Pathol Lab Med.1996; 120: 288–291.
9.
JohnsonE.S., GriswoldC.M.. Oncogenic retroviruses of cattle, chickens and turkeys: potential infectivity and oncogenicity for humans.Med Hypotheses.1996; 46: 354–356.
10.
ParsonnetJ., FriedmanG.D., VandersteenD.P.. Helicobacter pylori infection and the risk of gastric carcinoma.N Engl J Med.1991; 325: 1127–1131.
11.
Veldhuyzen van ZantenS.. Helicobacter pylori and duodenal ulcer, gastric cancer, and non-ulcer dyspepsia: a review.ACP J Club.1994; 62–64.
12.
WotherspoonA.C., DoglioniC., DissT.C.. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.Lancet.1993; 342: 575–577.
13.
BayerdorfferE., NeubauerA., RudolphB.. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.Lancet.1995; 345: 1591–1594.
14.
ChangF., SyrjanenS., WangL.. Infectious agents in the etiology of esophageal cancer.Gastroenterology.1992; 103: 1336–1348.
15.
OhshimaH., BartschH.. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis.Mutat Res.1994; 305: 253–264.
16.
IshiiA., MatsuokaH., AjiT.. Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review.Mutat Res.1994; 305: 273–281.
17.
GentileJ.M., GentileG.J.. Implications for the involvement of the immune system in parasite-associated cancers.Mutat Res.1994; 305: 315–320.
18.
PeetersE.G.. Geocancerology: a fundamental and universal discipline.J Environ Pathol Toxicol Oncol.1990; 10: 263–268.
19.
BlumeE.. 1971-1991: virus cancer research pays rich dividends.J Natl Cancer Inst.1991; 83: 1528–1531.
20.
YousdenK.. Human papillomavirus encoded oncoproteins and the regulation of cell growth. Symposium on Interferons and Interacting Cytokines; Cellular and Clinical Responses and Resistance. 1994: 23–26.
21.
RohnJ.L., GwynnS.R., LauringA.S.. Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model.Leukemia.1996; 10: 1867–1869.
22.
FischerC., PolskyB.. Retroviruses and cancer.Infect Med.1994; 11: 584–586.
23.
KaplanL.D., AbramsD.I., FeigalE.. AIDS-associated non-Hodgkin's lymphoma in San Francisco.JAMA.1989; 261: 719–724.
24.
MorrisJ.D., EddlestonA.L., CrookT.. Viral infection and cancer.Lancet.1995; 346: 754–758.
25.
RodriguezM.M., DelgadoP.I., PetitoC.K.. Epstein-Barr virus-associated primary central nervous system lymphoma in a child with acquired immunodeficiency syndrome: a case report and review of the literature.Arch Pathol Lab Med.1997; 121: 1287–1291.
26.
SelikR.M., ChuS.Y., WardJ.W.. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.Ann Intern Med.1995; 123: 933–936.
TrottierA.M., CoutleeF., LeducR.. Human immunodeficiency virus infection is a major risk factor for detection of human papillomavirus DNA in esophageal brushings.Clin Infect Dis.1997; 24: 565–569.
29.
KhabbazR.F., OnoratoI.M., CannonR.O.. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.N Engl J Med.1992; 326: 375–380.
PaterliniP., GerkenG., NakajimaE.. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.N Engl J Med.1990; 323: 80–85.
32.
MeliefC.J.. The prospects for immunotherapy of virus associated cancers.Br J Cancer.1994; 69(suppl 21): 4. Abstract.
33.
IwarsonS., NorkransG., WejstalR.. Hepatitis C: natural history of a unique infection.Clin Infect Dis.1995; 20: 1361–1370.
ChangY., MooreP.S.. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS.Infect Agents Dis.1996; 5: 215–222.
36.
MoniniP., de LellisL., FabrisM.. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen.N Engl J Med.1996; 334: 1168–1172.
37.
GaoS.J., KingsleyL., HooverD.R.. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.N Engl J Med.1996; 335: 233–241.
SmithM.. Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood.J Immunother.1997; 20: 89–100.
40.
ArmstrongA.A., MoradN.A., AngusB.. Incidence of Epstein-Barr virus (EBV) among pediatric Hodgkin's disease patients.J Pathol.1992; 168(suppl): 126A.
41.
FranklinJ.L., BhatiaK.G., AmbinderR.F.. Epstein-Barr virus (EBV) in Hodgkin's disease (HD) and Burkitt's lymphoma (BL) from developing countries.Proc Annu Meet Am Assoc Cancer Res.1995; 36: A1664.
LeeE.S., LockerJ., NalesnikM.. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.N Engl J Med.1995; 332: 19–25.
44.
McClainK.L., LeachC.T., JensonH.B.. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS.N Engl J Med.1995; 332: 12–18.
Cordell-SmithJ., PringleJ.H., HenryK.. HIV-associated lymphomas: an inverse correlation between p53 expression and Epstein-Barr virus infection.J Pathol.1995; 175(suppl): 113A.
47.
KamelO.W., van de RijnM., WeissL.M.. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.N Engl J Med.1993; 328: 1317–1321.
48.
LugmaniY.A., ShoushaS.. Epstein-Barr virus in breast carcinoma.J Pathol.1993; 170(suppl): 344A.
49.
RowlandsD.C., ItoM., ManghamD.C.. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.J Pathol.1993; 170(suppl): 336A.
50.
AozasaK., OhsawaM., KannoH.. Malignant lymphoma developing in the long-standing pyothorax.J Pathol.1995; 175(suppl)153A.
51.
LeibowitzM.J., McAllisterW.T., StrohlW.A.. Advances in cancer: viruses as causes of human cancer.N J Med.1986; 83: 603–608.
52.
PathmanathanR., PrasadU., SadlerR.. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.N Engl J Med.1995; 333: 693–698.
53.
AlaniR.M., MungerK.. Human papillomaviruses and associated malignancies.J Clin Oncol.1998; 16: 330–337.
54.
BeutnerK.R., TyringS.. Human papillomavirus and human disease.Am J Med.1997; 102(5A): 9–15.
55.
WalboomersJ.M., de Roda HusmanA.M., Van den BruleA.J.. Detection of genital human papillomavirus infections: critical review of methods and prevalence studies in relation to cervical cancer. In: SternP.L., StanleyM.A., eds. Human Papillomaviruses and Cervical Cancer: Biology and Immunology.New York, NY: Oxford University Press;1994: 41.
56.
PfisterH.. The role of human papillomavirus in anogenital cancer.Obstet Gynecol Clin North Am.1996; 23: 579–595.
57.
SunX.W., KuhnL., EllerbrockT.V.. Human papillomavirus infection in women infected with the human immunodeficiency virus.N Engl J Med.1997; 337: 1343–1349.
58.
StegnerH.E.. Cervical adenocarcinoma: a human papillomavirus related lesion.Cervix Lower Female Genital Tract.1992; 10: 133–137.
59.
FriisS., KjaerS.K., FrischM.. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata.J Infect Dis.1997; 175: 743–748.
60.
Human papillomaviruses and cervical cancer: biology and immunology. In: SternP.L., StanleyM.A., eds. Human Papillomaviruses and Cervical Cancer: Biology and Immunology.New York, NY: Oxford University Press; 1994: 226.
61.
TurekL.P., SmithE.M.. The genetic program of genital human papillomaviruses in infection and cancer.Obstet Gynecol Clin North Am.1996; 23: 735–758.
62.
HowleyP.M., MungerK., ScheffnerM.. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.FASEB J.1992; 6: A1.
63.
SternP.L., Duggan-KeenM.. MHC expression in the natural history of cervical cancer.Human Papillomaviruses and Cervical Cancer: Biology and Immunology. In: SternP.L., StanleyM.A., eds. New York, NY: Oxford University Press; 1994: 162.
64.
StarkL.A., ArendsM.J., McLarenK.. Many different human papillomavirus types are detected in cutaneous tumors from renal allograft recipients.J Pathol.1993; 170(suppl): 409A.
65.
HeD., TsaoS.W.. The clinical significance of p53 gene and overexpression in esophageal squamous cell carcinoma and its relationship with HPV infection in Chinese patients.Proc Annu Meet Am Assoc Cancer Res.1996; 37: A1274.
66.
PoljakM., CerarA., SemeK.. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review.Hum Pathol.1998; 29: 266–271.
67.
BrachmanD.G., NodzenskiE., GravesD.. Human papilloma virus 16 infection may play a role in human tonsillar carcinoma.Proc Annu Meet Am Assoc Cancer Res.1994; 35: A3684.
68.
PazI.B., CookN., Odom-MaryonT.. Human papilloma virus (HPV) infection is not a predictor of survival in head and neck cancer.Proc Annu Meet Am Assoc Cancer Res.1995; 36: A1196.
69.
ChibaI., ShindohM., YasudaM.. Mutations in the p53 gene and human papillomavirus (HPV) infection in squamous cell carcinomas of the oral cavity.Proc Annu Meet Am Assoc Cancer Res.1995; 36: A3324.
70.
HarafD., NodzenskiE., MickR.. HPV infection and p53 mutation in squamous cell head and neck cancer.Proc Annu Meet Am Assoc Cancer Res.1995; 14: A851.
71.
PoljakM.. Human papillomaviruses in laryngeal and esophageal squamous cell papillomas and carcinoma.Anticancer Res.1995; 15(5A): 1784–1785.
72.
LucasS.B., LewallenS., WaddellK.. Conjunctival carcinoma in Africa: multifactorial etiologies including HIV and human papilloma virus infections.J Pathol.1995; 176(suppl): 45A.
MimsC.A.. Important diseases with a possible viral aetiology.Adv Exp Med Biol.1989; 257: 135–145.
75.
FrischM., GlimeliusB., van den BruleA.J.. Sexually transmitted infection as a cause of anal cancer.N Engl J Med.1997; 337: 1350–1358.
76.
FurihataM., YamasakiI., IdoE.. Detection of human papillomavirus (type-16, -18) DNA and aberrant p53 protein in renal pelvic and ureteral cancer.Proc Annu Meet Jpn Cancer Assoc.1994; 6: 545. Abstract.
77.
SaeedF.A.. Detection of human papillomavirus type 16 and 18 DNA in human prostatic adenocarcinomas.Diss Abstr Int.1992; 53: 2135.
78.
WideroffL.J.. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males.Diss Abstr Int [B].1994; 54: 3581.
79.
RhimJ.S., WebberM.M., WilliamsD.E.. Human papillomavirus type 18 DNA immortalizes normal adult human prostate epithelial cells.Proc Annu Meet Am Assoc Cancer Res.1993; 34: A693.